Navigation Links
Echo Therapeutics to Present at Rodman & Renshaw 2009 Annual Global Investment Conference
Date:9/3/2009

FRANKLIN, Mass., Sept. 3 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the Rodman & Renshaw 2009 Annual Global Investment Conference on Friday September 11, 2009 at 2:25pm ET. The presentation will occur live and will be held at The New York Palace Hotel in New York, NY.

"We look forward to presenting Symphony, our needle-free, continuous glucose monitoring technology, and Prelude, our needle-free skin preparation technology for transdermal drug delivery, to the large audience of industry leaders, institutional and retail investors from around the world who will be attending the conference. We also plan to provide an update on our notable progress toward our goal of making Symphony and Prelude available to physicians and patients in early 2010," stated Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.

About Echo Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements tha
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences
2. Selexis and NKT Therapeutics Enter Into Research Services Agreement
3. FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone
4. Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
5. Nile Therapeutics Reports 2009 Second Quarter Financial Results
6. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
7. Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement
8. Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record
9. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
10. Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd.
11. Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... New York, N.Y. (PRWEB) September 17, 2014 ... for fans taking part in the fitness industry’s most ... in Las Vegas, NV. Two fans will each take ... fully loaded with Neon Sport supplements and gear. Fitmark ... booth during the Olympia Expo, September 19-20th. , ...
(Date:9/17/2014)... September 17, 2014 According to ... ), the leading global authority in medical device ... and regeneration market is expected to exceed ... into breast reconstruction, hernia repair, dural repair, vaginal ... and dental soft tissue regeneration. , Approximately ...
(Date:9/17/2014)... Kamut International is pleased to announce ... in Michael Angelo’s new “Made With Organic” ready-made, frozen ... lasagna ready made, frozen meal. Michael Angelo’s products feature ... new products align well with Kamut International’s mission to ... wheat must be grown certified organic. , The new ...
(Date:9/17/2014)... PA (PRWEB) September 17, 2014 ... and increase efficiency. Today, Pharmacy Healthcare Solutions, a ... a web-based analysis and forecasting tool that enables ... maximizing the impact of medications on improved patient ... Reporting uses pharmacy purchase data to identify areas ...
(Date:9/17/2014)... HealthDay Reporter , TUESDAY, ... Americans dying from accidental overdoses of narcotic painkillers jumped ... Tuesday. Deaths from overdoses of drugs such as ... per 100,000 people to 5.4 per 100,000, according ... That means about 3,000 people died in 1999 ...
Breaking Medicine News(10 mins):Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:Bilateral Breast Reconstruction Rate in the U.S. is one of the Highest in the World 2Health News:Bilateral Breast Reconstruction Rate in the U.S. is one of the Highest in the World 3Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 2Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 3
... ... for Haiti,s Earthquake Victims, New Campaign Seeks Participants in Healing Service for Chile on ... ... and Master Zhi Gang Sha and the Institute of Soul Healing and Enlightenment, shortly after ...
... ... ... ... ...
... ... ... , ... , , ...
... ... ... ... ...
... of the major cancers in Northeast Thailand. This cancer ... mortality rates. Overexpression of Met, a hepatocyte growth factor ... is correlated with progression of this type of cancer. ... cell scattering, invasion and proliferation. Although a number of ...
... to see the human brain at work, a new generation ... appeal while it is still being designed, according to a ... University. So-called "neuromarketing" takes the tools of modern brain ... somewhat abstract likes and dislikes of customer decision-making. Though ...
Cached Medicine News:Health News:Master Zhi Gang Sha Dedicates Soul Healing Blessings for Humanity Service to Chile's Earthquake Victims 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 3Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 4Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 5Health News:Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis 2Health News:Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis 3Health News:Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis 4Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 2Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 3Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 4Health News:Community Pharmacists Rise to Meet Winter Weather Challenges, Survey Finds 5Health News:Different signaling pathways of cholangiocarcinoma 2
(Date:9/17/2014)... --  myMatrixx, a pharmacy and ancillary medical benefit manager for workers, ... has awarded myMatrixx with a "Best Places to Work ... row. Best Places to Work is ... Best Companies Group.  The competition, which involves months of ... insurance industry companies with at least 25 employees in ...
(Date:9/17/2014)... , Sept. 17, 2014  NuView Life ... global licensing and collaboration agreement with Otsuka Pharmaceutical ... NuView,s investigative genomic-based diagnostic biomarker to detect cancers ... includes all other future diagnostic-imaging applications. NuView retains ... therapeutic delivery and in-vitro urine screen applications. ...
(Date:9/17/2014)... Cardiac Dimensions ® , Inc. today announced ... II clinical trial of its enhanced CARILLON Mitral ... mitral regurgitation, functional improvement, quality of life and ... data, which was consistent with previous trials of ... 26 th annual Transcatheter Cardiovascular Therapeutics Conference ...
Breaking Medicine Technology:myMatrixx Honored with "Best Places to Work in Insurance" Award 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3
... , SAN MATEO, Calif., July 24 ... the preliminary results of a short-term clinical study (Study ... following pretreatment with an FDA-approved topical anesthetic. As part ... U.S. Food and Drug Administration (FDA) requested the study ...
... G rowth factor enhances ... stem cells , , BOSTON, July ... Boston have now laid the groundwork for regenerating heart tissue after a heart ... In the July 24 issue of Cell , they show that a ...
Cached Medicine Technology:NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study 2NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study 3NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study 4Injection Reverses Heart-Attack Damage 2Injection Reverses Heart-Attack Damage 3
... The ThromCat™ System is the first thrombectomy ... strength and simplicity for the full range ... Heliflex™ technology, the new ThromCat™ System flushes, ... of 700 mmHg and incorporates advanced vessel-wall ...
... telescoping plate design integrates the ... and vertebral column spacer. This ... need for supplemental fixation while ... bone graft to be delivered ...
... Tendril ST leads are ... leads, designed to bring ... and flexibility to you ... pre-formed "J leads are ...
The MYO-VAD is a novel cardiac support system with unique, life-saving features....
Medicine Products: